ViewRay, Inc.

ViewRay is a medical technology company based in Gainesville, FL, focused on revolutionizing radiation therapy for the benefit of cancer patients. The ViewRay Renaissance™ will be the world's first radiation therapy device that allows real-time imaging of the cancer patient during beam-on radiation. For the first time, the treating professional will know precisely where the dose is going and what it is actually hitting. ViewRay holds the worldwide exclusive license to this technology which was conceived at the University of Florida by Dr. James F. Dempsey.

The Renaissance™ is intended to offer oncology practitioners the unprecedented power to accurately control and measure all aspects of radiation therapy, while improving the quality of life and survival rates for their patients. The Renaissance™ advantages include:

• Real-time radiation treatment tracking and enhanced imaging using MRI;
• Accurate dosage control and delivery, expediting the prescribed treatment cycle while preventing damage to healthy tissue surrounding the tumor;
• Elimination of potentially harmful CT imaging;
• Ultimate real-time treatment delivery adjustment to account for organ motion - a critical concern in the most common forms of cancer such as lung, prostate, breast, colon and uterine;
• A radiation source that is technically less complex than a linac and subsequently significantly less expensive to develop, manufacture, and maintain;
• A system that will allow for new workflow efficiencies, offering purchasers reduced overhead and increased patient throughput.

The World Health Organization estimates that cancer will become the leading cause of death in the world. More than 17 million cases have been identified worldwide since 1990, and cancer causes more than 6 million deaths annually. Nearly 60% of all cancer patients are candidates for radiation therapy, with the global market currently estimated at $1.6 billion.

http://www.viewray.com/